Alkindi Sprinkle (Hydrocortisone) Patent Expiration, LOE Window & CMS Spending

Alkindi Sprinkle (Hydrocortisone) by Eton: FDA Orange Book LOE 2034-05-12, 17 AB generics, $8.4M 2024 CMS Part D & Medicaid spend, and 12 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorEton
FDA Application & PathwayN213876 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2034-05-12
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors17
2024 CMS Total Public Spend$8.4M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$8.4M
Reported Wholesale Price Change (CA SB 17)12 WAC filings (max 32.7% 2-yr change)